miR-154 inhibits prostate cancer cell proliferation by targeting CCND2

Chen Zhu; Pengfei Shao; Meiling Bao; Pu Li; Hai Zhou; Hongzhou Cai; Qiang Cao; Liangjun Tao; Xiaoxin Meng; Xiaobing Ju; Chao Qin; Jie Li; Changjun Yin

doi:10.1016/j.urolonc.2012.11.013

JOURNAL ARTICLE

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2

Chen Zhu Pengfei Shao Meiling Bao Pu Li Hai Zhou Hongzhou Cai Qiang Cao Liangjun Tao Xiaoxin Meng Xiaobing Ju Chao Qin Jie Li Changjun Yin

Year: 2013 Journal: Urologic Oncology Seminars and Original Investigations Vol: 32 (1)Pages: 31.e9-31.e16 Publisher: Elsevier BV

DOI: 10.1016/j.urolonc.2012.11.013

Get Full-Text PDF Get Analytical Report

Keywords:

Flow cytometry microRNA Cell growth Cancer research Prostate cancer Biology Reverse transcription polymerase chain reaction Molecular biology Cancer Chemistry Messenger RNA Gene Genetics

Metrics

Cited By

2.56

FWCI (Field Weighted Citation Impact)

Refs

0.90

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

MicroRNA in disease regulation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

RNA Research and Splicing

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

RNA modifications and cancer

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2

Metrics

Citation History

Topics

Related Documents

miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration

miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells

MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.

miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2